Shaolin Zeng
Overview
Explore the profile of Shaolin Zeng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeng S, Cui J, Zhang Y, Zheng Z
Inflammation
. 2022 Mar;
45(4):1548-1558.
PMID: 35304668
The dysfunction of airway smooth muscle cells (ASMCs) is one of the key factors in the pathogenesis of asthma. How miR-98-5p works in asthma has not been completely elucidated. This...
2.
Zeng S, Cui J, Zhang Y, Zheng Z, Meng J, Du J
Bioengineered
. 2022 Feb;
13(3):5396-5406.
PMID: 35172671
The excessive proliferation and the deposition of extracellular matrix (ECM) of airway smooth muscle (ASM) cells facilitates airway remodeling in asthma. This study explores how microRNA-15b-5p (miR-15b-5p) functions in modulating...
3.
Zhang Y, Zeng S, Wang T
Bioengineered
. 2021 Nov;
12(2):12767-12777.
PMID: 34747300
Dysregulated circular RNAs (circRNAs) are involved in the progression of non-small cell lung cancer (NSCLC). However, the role of has_circ_0002360 (circ_0002360) in NSCLC has rarely been reported. In this study,...
4.
Zhao K, Ai L, Zhao Y, Wang T, Zheng Z, Zeng S, et al.
Epidemiol Infect
. 2021 Feb;
149:e62.
PMID: 33594967
Coronavirus disease 2019 (COVID-19) is a newly emerged disease with various clinical manifestations and imaging features. The diagnosis of COVID-19 depends on a positive nucleic acid amplification test by real-time...
5.
Wang M, Zhao Y, Hu W, Zhao D, Zhang Y, Wang T, et al.
Clin Infect Dis
. 2020 Sep;
73(11):e4012-e4019.
PMID: 32955081
Background: We aimed to evaluate the efficacy and safety of leflunomide, an approved dihydroorotate dehydrogenase inhibitor, to treat coronavirus disease 2019 (COVID-19) patients with prolonged postsymptomatic viral shedding. Methods: We...
6.
Zhao D, Wang M, Wang M, Zhao Y, Zheng Z, Li X, et al.
Int J Infect Dis
. 2020 Aug;
99:219-225.
PMID: 32758693
Objectives: To investigate the proportion and characteristics of asymptomatic infection among healthcare workers (HCWs). Methods: This study retrospectively investigated 1407 HCWs who were screened for COVID-19 by chest computed tomography...
7.
Hu K, Wang M, Zhao Y, Zhang Y, Wang T, Zheng Z, et al.
Virol Sin
. 2020 Jul;
35(6):725-733.
PMID: 32696396
We recently reported that inhibitors against human dihydroorotate dehydrogenase (DHODH) have broad-spectrum antiviral activities including their inhibitory efficacies on SARS-CoV-2 replication in infected cells. However, there are limited data from...
8.
Zhao K, Li R, Wu X, Zhao Y, Wang T, Zheng Z, et al.
Eur J Clin Microbiol Infect Dis
. 2020 Jul;
39(12):2279-2287.
PMID: 32651736
Recent reports have showed that a proportion of patients with Coronavirus Disease 2019 (COVID-19) presented elevated leukocyte count. Clinical data about these patients is scarce. We aimed to evaluate the...
9.
Zeng S, Cao Y, Sang W, Li T, Gan N, Zheng L
Int J Mol Sci
. 2012 Jul;
13(5):6382-6398.
PMID: 22754371
In this paper, Fe(3)O(4) nanoparticles (Fe(3)O(4) NPs) grafted carboxyl groups of multiwalled carbon nanotubes with cationic polyelectrolyte poly (dimethyldiallylammonium chloride) (PDDA) (MWCNTs-COO(-)/PDDA@Fe(3)O(4)), are successfully synthesized and used for the extraction...